Children with Diabetic Ketoacidosis

Launched by ASSIUT UNIVERSITY · Sep 13, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how children with diabetic ketoacidosis (DKA) respond to treatment. DKA is a serious condition that can happen when diabetes is not well managed, causing a dangerous buildup of acids in the blood. The study will monitor how well the treatment works by checking important health indicators like blood sugar levels and electrolytes, which are minerals in the body that help with many functions. Researchers are also looking out for complications that can arise during treatment, such as brain swelling or kidney problems.

To participate in this trial, children ages 1 to 16 who are hospitalized with DKA may be eligible. However, those with certain other health conditions, like severe liver or kidney problems, or a history of cancer, cannot take part. Since the trial is not yet open for enrollment, it’s a good time for families to learn about this important research that aims to improve care for children facing this serious condition. Participants can expect close monitoring and care as part of the study, helping researchers learn how to better treat DKA in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Hospitalized diabetic patients aged from 1 year to 16 years with diabetic ketoacidosis
• Exclusion Criteria:
• • 1. Other endocrine diseases as thyroid disease or pituitary disease
• • 2. Severe Hepatic Dysfunction or Chronic Kidney Dysfunction: Patients with significant liver or kidney impairment were excluded from the study.
• • 3. History of Malignant Tumor: The study did not include individuals with a previous history of any malignant tumor